Cytotoxic T lymphocyte clone specific for autologous human hepatocellular carcinoma cell line SUHC-1

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 1, 1998, Pages 29-33

  Yoshizawa, Kaname ^a   Ota, Masao ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; Hepatocellular carcinoma; T cell receptor complementary determining region 3

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CARCINOMA CELL; CELL LINE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; ERYTHROLEUKEMIA CELL; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; VIRUS CELL TRANSFORMATION;

EID: 0031882257     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00541.x     Document Type: Article

References (29)

1. Anichini A, Fossati G, Parmiani G. Clonal analysis of the cytolytic T-cell response to human tumors. Immunol. Today 1987; 8: 385-9.
2. Mukherji B, Macalister TJ. Clonal analysis of cytotoxic T cell response against human melanoma. J. Exp. Med. 1983; 158: 240-5.
3. DeVries JE, Spits H. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J. Immunol. 1984; 132: 510-19.
4. Ichino Y, Ishikawa T. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor. Jpn. J. Cancer Res. 1984; 75: 436-41.
5. Knuth A, Danowski B, Oettgen HF, Old LJ. T-cell-mediated cytotoxicity against autologous malignant melanoma: Analysis with interleukin 2-dependent T-cell cultures. Proc. Natl Acad. Sci. USA 1984; 81: 3511-15.
6. Sato T, Sato N, Takahashi S, Koshiba H, Kikuchi K. Specific cytotoxicity of a long-term cultured T cell clone on human autologous mammary cancer cells. Cancer Res. 1986; 46: 4384-9.
7. Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ. T cell receptor Vb2 and Vb6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. J. Immunol. 1993; 151: 5472-80.
8. Usuda S, Yoshizawa K, Yabu K, Kiyosawa K. Immunological responses against an autologous human hepatocellular carcinoma cell line. J. Gastroenterol. Hepatol. 1993; 8: 517-23.
9. Bernhard H, Karbach J, Wolfel T et al. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int. J. Cancer 1994; 59: 837-42.
10. Slingluff CL Jr, Cox AL, Stover JM Jr, Moore MM, Hunt DF, Engelhard VH. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: Epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res. 1994; 54: 2731-7.
11. Kubo H, Abe J, Obata F et al. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Cancer Res. 1996; 56: 2368-74.
12. Van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
13. Gaugler B, Van den Eynde B, Van der Bruggen P et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994; 179: 921-30.
14. Boel P, Wildmann C, Sensi ML et al. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 167-75.
15. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 1995; 182: 689-98.
16. Brichard V, Van Pel A, Wolfel T et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1993; 178: 489-95.
17. Coulie PG, Brichard V, Van Pel A et al. A new gene coding for differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994; 180: 35-42.
18. Kawakami Y, Eliyahu S, Delgaldo CH et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Prof. Natl Acad. Sci. USA 1994; 91: 3515-19.
19. Bakker ABH, Schreurs MWJ, de Boer AJ et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 1994; 179: 1005-9.
20. Cox AL, Skipper J, Chen Y et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716-19.
21. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 1995; 181: 799-804.
22. Guilloux Y, Lucas S, Brichard VG et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-Acetylglucosaminyltransferase V gene. J. Exp. Med. 1996; 183: 1173-83.
23. Robbins PF, El-Gamil M, Li YF et al. A mutated b-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 1996; 183: 1185-92.
24. Aruga A, Yamauchi K, Takasaki K, Furukawa T, Hanyu F. Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization. Int. J. Cancer 1991; 49: 19-24.
25. Yoshizawa K, Kiyosawa K, Usuda S et al. New hepatocellular carcinoma cell line SUHC-1 established from a patient with hepatitis C virus RNA in serum. Jpn. J. Cancer Res. 1992; 83: 871-7.
26. Ota M, Geiger MJ, Rosen-Broson S, Hurley CK, Eckels DD. Diverse usage of human T-cell receptor gene segments in HLA-DR1 allospecific T-cell clones. Human Immunol. 1996; 49: 122-9.
27. Itoh Y, Iwakiri S, Kitajima K et al. Lack of detectable reverse transcriptase activity in human and chimpanzee sera with a high infectivity for non-A, non-B hepatitis. J. Gen. Virol. 1990; 67: 777-9.
28. Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M. The T-cell receptor Vb gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res. 1992; 52: 5913-20.
29. Rosenberg SA. Gene therapy for cancer. JAMA 1992; 268: 2416-19.